Antithyroid peroxidase antibody positivity is associated with lower incidence of metastasis in breast cancer

Kemal,Yasemin; Demirag,Guzin; Ekiz,Kubilay; Yucel,Idris

doi:10.3892/mco.2015.521

Antithyroid peroxidase antibody positivity is associated with lower incidence of metastasis in breast cancer

Authors:
- Yasemin Kemal
- Guzin Demirag
- Kubilay Ekiz
- Idris Yucel
View Affiliations

Affiliations: Department of Medical Oncology, Faculty of Medicine, Ondokuz Mayis University, Samsun 55139, Turkey, Department of Internal Medicine, Faculty of Medicine, Ondokuz Mayis University, Samsun 55139, Turkey
Published online on: March 2, 2015 https://doi.org/10.3892/mco.2015.521
Pages: 629-632

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Thyroid extracts were first used to treat patients with metastatic breast cancer over a century ago. Since then, a number of studies have investigated the association between thyroid disorders and breast cancer. the presence of antibodies to thyroid peroxidase (TPOab) was recently reported to be associated with improved outcome in these patients. The aim of the present study was to evaluate the association between TPOab positivity and clinicopathological characteristics in breast cancer patients. The study included 318 newly diagnosed cases of breast cancer treated at Ondokuz Mayis University Hospital, Samsun, Turkey, between 2008 and 2012. Serum thyroid‑stimulating hormone, free triiodothyronine and free thyroxine levels were measured at the time of diagnosis. Of the 318 patients, 253 were considered to be TPOab‑negative (TPOab ≤34 IU/ml) and 65 TPOab‑positive (TPOab >34 IU/ml). No cases with distant metastases were found in the TPOab‑positive group. However, 20 (7.9%) of the 253 patients displayed distant metastases in the TPOab‑negative group (P=0.01). Therefore, TPOab positivity was found to be associated with a lower incidence of metastasis in breast cancer patients.

View Figures

View References

1	Beatson GT: On the treatment of inoperable cases of carcinoma of the mamma: suggestions for a new method of treatment, with illustrative cases. Lancet. 2:104–107. 1986.
2	Altieri A, Tavani A, Gallus S, Bosetti C, Talamini R, Franceschi S, Levi F and La Vecchia C: Correspondence re: Simon et al.Do thyroid disorders increase the risk of breast cancer? Cancer Epidemiol Biomarkers Prev. 12:684–686. 2003.PubMed/NCBI
3	Ito K and Maruchi N: Breast cancer in patients with Hashimoto's thyroiditis. Lancet. 2:1119–1121. 1975. View Article : Google Scholar : PubMed/NCBI
4	Rasmusson B, Feldt-Rasmussen U, Hegedüs L, Perrild H, Bech K and Høier-Madsen M: Thyroid function in patients with breast cancer. Eur J Cancer Clin Oncol. 23:553–556. 1987. View Article : Google Scholar : PubMed/NCBI
5	Shering SG, Zbar AP, Moriarty M, McDermott EW, O'Higgins NJ and Smyth PP: Thyroid disorders and breast cancer. Eur J Cancer Prev. 5:504–506. 1996.PubMed/NCBI
6	Maruchi N, Annegers JF and Kurland LT: Hashimoto's thyroiditis and breast cancer. Mayo Clin Proc. 51:263–265. 1976.PubMed/NCBI
7	Anker GB, Lønning PE, Aakvaag A and Lien EA: Thyroid function in postmenopausal breast cancer patients treated with tamoxifen. Scand J Clin Lab Invest. 58:103–107. 1998. View Article : Google Scholar : PubMed/NCBI
8	Kurland LT and Annegers JF: Letter: Breast cancer and Hashimoto's thyroiditis. Lancet. 1:8081976. View Article : Google Scholar : PubMed/NCBI
9	Nogueira CR and Brentani MM: Triiodothyronine mimics the effect of estrogen in breast cancer cell lines. J Steroid Biochem Mol Biol. 59:271–279. 1996. View Article : Google Scholar : PubMed/NCBI
10	Dinda S, Sanchez A and Moudgil V: Estrogen-like effects of thyroid hormone on the regulation of tumor suppressor proteins, p53 and retinoblastoma, in breast cancer cells. Oncogene. 21:761–768. 2002. View Article : Google Scholar : PubMed/NCBI
11	Vonderhaar BK and Greco AE: Lobulo-alveolar development of mouse mammary glands is regulated by thyroid hormones. Endocrinology. 104:409–418. 1979. View Article : Google Scholar : PubMed/NCBI
12	Mittra I, Perrin J and Kumaoka S: Thyroid and other autoantibodies in British and Japanese women: an epidemiological study of breast cancer. Br Med J. 1:257–259. 1976. View Article : Google Scholar : PubMed/NCBI
13	Zophel K, Roggenbuck D and Schott M: Clinical review about TRAb assay's history. Autoimmun Rev. 9:695–700. 2010. View Article : Google Scholar : PubMed/NCBI
14	McLachlan SM and Rapoport B: The molecular biology of thyroid peroxidase: cloning, expression, and role as autoantigen in autoimmune thyroid disease. Endocr Rev. 13:192–206. 1992. View Article : Google Scholar : PubMed/NCBI
15	Khoury EL, Hammond L, Bottazzo GF and Doniach D: Presence of the organ-specific ‘microsomal’ autoantigen on the surface of human thyroid cells in culture: its involvement in complement-mediated cytotoxicity. Clin Exp Immunol. 45:316–328. 1981.PubMed/NCBI
16	Mariotti S, Caturegli P, Piccolo P, Barbesino G and Pinchera A: Antithyroid peroxidase autoantibodies in thyroid diseases. J Clin Endocrinol Metab. 71:661–669. 1990. View Article : Google Scholar : PubMed/NCBI
17	Feldt-Rasmussen U, Høier-Madsen M, Bech K, et al: Anti-thyroid peroxidase antibodies in thyroid disorders and non-thyroid autoimmune diseases. Autoimmunity. 9:245–254. 1991. View Article : Google Scholar : PubMed/NCBI
18	Gogas J, Kouskos E, Tseleni-Balafouta S, Markopoulos C, Revenas K, Gogas G and Kostakis A: Autoimmune thyroid disease in women with breast carcinoma. Eur J Surg Oncol. 27:626–630. 2001. View Article : Google Scholar : PubMed/NCBI
19	Myhill J, Reeve TS and Hales IB: Thyroid function in breast cancer. Acta Endocrinol (Copenh). 51:290–300. 1996.
20	Giani C, Fierabracci P, Bonnaci R, et al: Relationship between breast cancer and thyroid disease: relevance of autoimmune thyroid disorders in breast malignancy. J Clin Endocrinol Metab. 81:990–994. 1996. View Article : Google Scholar : PubMed/NCBI
21	Smyth PP: Autoimmune thyroid disease and breast cancer: a chance association? J Endocrinol Invest. 23:42–43. 2000. View Article : Google Scholar : PubMed/NCBI
22	Sarlis NJ, Gourgiotis L, Pucino F and Tolis GJ: Lack of association between Hashimoto thyroiditis and breast cancer: a quantitative research synthesis. Hormones (Athens). 1:35–41. 2002. View Article : Google Scholar : PubMed/NCBI
23	Simon MS, Tang MT, Bernstein L, et al: Do thyroid disorders increase the risk of breast cancer? Cancer Epidemiol Biomarkers Prev. 11:1574–1578. 2002.PubMed/NCBI
24	Cristofanilli M, Yamamura Y, Kau SW, et al: Thyroid hormone and breast carcinoma. Primary hypothyroidism is associated with a reduced incidence of primary breast carcinoma. Cancer. 103:1122–1128. 2005. View Article : Google Scholar : PubMed/NCBI
25	Farahati J, Roggenbuck D, Gilman E, Schütte M, Jagminaite E, Seyed Zakavi R, Löning T and Heissen E: Anti-thyroid peroxidase antibodies are associated with the absence of distant metastases in patients with newly diagnosed breast cancer. Clin Chem Lab Med. 50:709–714. 2012. View Article : Google Scholar : PubMed/NCBI
26	Prinzi N, Baldini E, Sorrenti S, et al: Prevalence of breast cancer in thyroid diseases: results of a cross-sectional study of 3,921 patients. Breast Cancer Res Treat. 144:683–688. 2014. View Article : Google Scholar : PubMed/NCBI
27	Rodien PM, Madec AM, Ruf J, et al: Antibody-dependent cell-mediated cytotoxicity in autoimmune thyroid disease: relationship to antithyroperoxidase antibodies. J Clin Endocrinol Metab. 81:2595–2600. 1996. View Article : Google Scholar : PubMed/NCBI
28	Bhattacharya A and Vonderhaar BK: Specific binding proteins for 3, 5, 30-triiodothyronine in mouse mammary epithelium. J Cell Biol. 75:47a1977.
29	Selliti DF, Tseng YC and Latham KR: Nuclear thyroid hormone receptor in C3H/HeN mouse mammary glands and spontaneous tumors. Cancer Res. 43:1030–1038. 1983.PubMed/NCBI
30	Smallridge RC and Latham KR: Nuclear thyroid hormone receptor in human breast tumors. Clin Res. 28:4211980.
31	Cerbon MA, Pichon MF and Milgrom E: Thyroid hormone receptors in human breast cancer. Cancer Res. 41:4167–4173. 1981.PubMed/NCBI
32	Spitzweg C, Joba W, Eisenmenger W and Heufelder AE: Analysis of human sodium iodide symporter gene expression in extrathyroidal tissues and cloning of its complementary deoxyribonucleic acids from salivary gland, mammary gland, and gastric mucosa. J Clin Endocrinol Metab. 83:1746–1751. 1998. View Article : Google Scholar : PubMed/NCBI
33	Kilbane MT, Ajjan RA, Weetman AP, Dwyer R, McDermott EW, O'Higgins NJ and Smyth PP: Tissue iodine content and serum-mediated 125I uptake-blocking activity in breast cancer. J Clin Endocrinol Metab. 85:1245–1250. 2000. View Article : Google Scholar : PubMed/NCBI
34	Stadel BV: Dietary iodine and risk of breast, endometrial, and ovarian cancer. Lancet. 1:890–891. 1976. View Article : Google Scholar : PubMed/NCBI